Information about GlobalPharmacyMeds.to
List of countries where we can ship Cladribine:
Latest news releases on Cladribine:
Cladribine, sold under the brand name Leustatin among others, is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis) and B-cell ...
Background Cladribine provides immunomodulation through selective targeting of lymphocyte subtypes. We report the results of a 96-week phase 3 trial of a short-course ...
Evidence-based recommendations on cladribine tablets (Mavenclad) for highly active relapsing–remitting multiple sclerosis (MS) in adults
original article The new england journal of medicine 416 n engl j med 362;5 nejm.org february 4, 2010 A Placebo-Controlled Trial of Oral Cladribine for Relapsing ...
Op aanbeveling van de EMA heeft de Europese Commissie in augustus 2017 goedkeuring gegeven om het middel Cladribine (Mavenclad) op de markt te brengen.
LEUSTATIN (cladribine) Injection For Intravenous Infusion Only WARNING . LEUSTATIN (cladribine) Injection should be administered under the supervision of a
Mavenclad (cladribine) is a disease modifying drug treatment for relapsing remitting multiple sclerosis. Read more about Mavenclad in this A-Z entry.
European Union agency responsible for the protection of public and animal health through the scientific evaluation and supervision of medicines.
LITAK 2mg/ml solution for injection - Summary of Product Characteristics (SmPC) by LIPOMED GmbH
LEUSTAT (cladribine) Injection is a synthetic antineoplastic agent for continuous intravenous infusion. It is a clear, colourless, sterile, preservative-free ...